| Year |
Citation |
Score |
| 2020 |
Nath A, Oak A, Chen KY, Li I, Splichal RC, Portis J, Foster S, Walton SP, Chan C. Palmitate-induced IRE1-XBP1-ZEB signaling represses desmoplakin expression and promotes cancer cell migration. Molecular Cancer Research : McR. PMID 33106375 DOI: 10.1158/1541-7786.MCR-19-0480 |
0.542 |
|
| 2020 |
Grolmusz VK, Chen J, Emond R, Cosgrove PA, Pflieger L, Nath A, Moos PJ, Bild AH. Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model. Cancer Cell International. 20: 253. PMID 32565737 DOI: 10.1186/S12935-020-01337-1 |
0.339 |
|
| 2020 |
O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Research and Treatment. PMID 32378051 DOI: 10.1007/S10549-020-05603-8 |
0.303 |
|
| 2020 |
Nath A, Huang RS. Emerging role of long non-coding RNAs in cancer precision medicine. Molecular & Cellular Oncology. 7: 1684130. PMID 31993497 DOI: 10.1080/23723556.2019.1684130 |
0.337 |
|
| 2019 |
Pareek S, Nath A, Huang RS. MicroRNA targeting energy metabolism in ovarian cancer: a potent contender for future therapeutics. Annals of Translational Medicine. 7: S299. PMID 32016018 DOI: 10.21037/Atm.2019.11.15 |
0.358 |
|
| 2019 |
Nath A, Lau EYT, Lee AM, Geeleher P, Cho WCS, Huang RS. Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes. Proceedings of the National Academy of Sciences of the United States of America. PMID 31548386 DOI: 10.1073/Pnas.1909998116 |
0.373 |
|
| 2019 |
Nath A, Geeleher P, Huang RS. Long non-coding RNA transcriptome of uncharacterized samples can be accurately imputed using protein-coding genes. Briefings in Bioinformatics. PMID 30657858 DOI: 10.1093/Bib/Bby129 |
0.346 |
|
| 2019 |
Nath A, Lau EY, Lee AM, Geeleher P, Cho WC, Huang RS. Abstract 3578: Comprehensive pharmacogenomic analysis establishes lncRNAs as protein-coding independent biomarker of drug response in human cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3578 |
0.356 |
|
| 2018 |
Geeleher P, Nath A, Wang F, Zhang Z, Barbeira AN, Fessler J, Grossman RL, Seoighe C, Stephanie Huang R. Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity. Genome Biology. 19: 130. PMID 30205839 DOI: 10.1186/S13059-018-1507-0 |
0.394 |
|
| 2018 |
Nath A, Huang RS. Abstract 3897: Pharmacogenomic landscape of long non-coding RNAs in human cancers Cancer Research. 78: 3897-3897. DOI: 10.1158/1538-7445.Am2018-3897 |
0.405 |
|
| 2017 |
Wang F, Chang JT, Zhang Z, Morrison G, Nath A, Bhutra S, Huang RS. Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile. Oncotarget. 8: 115102-115113. PMID 29383145 DOI: 10.18632/Oncotarget.22870 |
0.369 |
|
| 2017 |
Geeleher P, Zhang Z, Wang F, Gruener RF, Nath A, Morrison G, Bhutra S, Grossman RL, Huang RS. Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies. Genome Research. PMID 28847918 DOI: 10.1101/Gr.221077.117 |
0.39 |
|
| 2017 |
Nath A, Wang J, Stephanie Huang R. Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia. Molecular Diagnosis & Therapy. PMID 28698977 DOI: 10.1007/S40291-017-0292-X |
0.339 |
|
| 2017 |
Geeleher P, Nath A, Huang RS. Institutional Profile: Pharmacogenomic research in R Stephanie Huang Laboratory. Pharmacogenomics. PMID 28290771 DOI: 10.2217/Pgs-2017-0031 |
0.356 |
|
| 2017 |
Geeleher P, Zhang Z, Wang F, Nath A, Bhutra S, Grossman R, Huang RS. Abstract 5035: IDWAS: Imputing drug response in large cohorts of cancer patients to discover novel predictive biomarkers Cancer Research. 77: 5035-5035. DOI: 10.1158/1538-7445.Am2017-5035 |
0.343 |
|
| 2017 |
Nath A, Geeleher P, Huang RS. Abstract 3481: Leveraging protein coding gene expression profiles to accurately impute lncRNA transcriptome of cancer cells Cancer Research. 77: 3481-3481. DOI: 10.1158/1538-7445.Am2017-3481 |
0.4 |
|
| 2016 |
Bilgin B, Nath A, Chan C, Walton SP. Characterization of transcription factor response kinetics in parallel. Bmc Biotechnology. 16: 62. PMID 27557669 DOI: 10.1186/S12896-016-0293-6 |
0.508 |
|
| 2016 |
Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Scientific Reports. 6: 18669. PMID 26725848 DOI: 10.1038/Srep18669 |
0.559 |
|
| 2016 |
Nath A, Wang F, Lenkala D, LaCroix B, Glavin N, Kipping-Johnson K, Geeleher P, Thirman M, Godley L, Raca G, Larson R, RSH. Abstract 2039: Exploring the longitudinal transcriptomic landscape of tyrosine kinase inhibitor treatment response in chronic myeloid leukemia patients Cancer Research. 76: 2039-2039. DOI: 10.1158/1538-7445.Am2016-2039 |
0.389 |
|
| 2016 |
Nath A, Wang F, Lenkala D, LaCroix B, Glavin N, Kipping-Johnson K, Geeleher P, Rich E, Thirman M, Godley L, Raca G, Larson R, Huang R. ID: 26: EXPLORING THE LONGITUDINAL TRANSCRIPTOMIC LANDSCAPE OF TYROSINE KINASE INHIBITOR TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS Journal of Investigative Medicine. 64: 935.2-936. DOI: 10.1136/Jim-2016-000120.50 |
0.377 |
|
| 2016 |
Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers Scientific Reports. 6. DOI: 10.1038/srep18669 |
0.476 |
|
| 2015 |
Nath A, Li I, Roberts LR, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Scientific Reports. 5: 14752. PMID 26424075 DOI: 10.1038/Srep14752 |
0.517 |
|
| 2015 |
Kowalsky CA, Faber MS, Nath A, Dann HE, Kelly VW, Liu L, Shanker P, Wagner EK, Maynard JA, Chan C, Whitehead TA. Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing. The Journal of Biological Chemistry. PMID 26296891 DOI: 10.1074/Jbc.M115.676635 |
0.419 |
|
| 2015 |
Nath A, Chan C. Abstract A1-58: Revisiting cancer energetics: Establishing a link between altered fatty-acid metabolism and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A1-58 |
0.569 |
|
| 2015 |
Nath A, Li I, Chan C. Abstract 5157: Elevated uptake of free fatty acids via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma Cancer Research. 75: 5157-5157. DOI: 10.1158/1538-7445.Am2015-5157 |
0.536 |
|
| 2013 |
Cho H, Wu M, Zhang L, Thompson R, Nath A, Chan C. Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells. Bmc Systems Biology. 7: 9. PMID 23339444 DOI: 10.1186/1752-0509-7-9 |
0.633 |
|
| 2013 |
Nath A, Chan C. Abstract C29: Free fatty acid induced epithelial to mesenchymal transition (EMT) in hepatocellular carcinoma cells Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-C29 |
0.542 |
|
| 2012 |
Hijazi H, Wu M, Nath A, Chan C. Ensemble Classification of Cancer Types and Biomarker Identification. Drug Development Research. 73: 414-419. PMID 25221378 DOI: 10.1002/Ddr.21032 |
0.491 |
|
| 2011 |
Wang X, Nath A, Yang X, Portis A, Walton SP, Chan C. Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells. Plos One. 6: e28138. PMID 22132232 DOI: 10.1371/Journal.Pone.0028138 |
0.612 |
|
| 2010 |
Yang X, Nath A, Opperman MJ, Chan C. The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells. Molecular Biology of the Cell. 21: 3449-58. PMID 20685959 DOI: 10.1091/Mbc.E10-06-0481 |
0.589 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Nath A, Cosgrove PA, Mirsafian H, Christie EL, Pflieger L, Copeland B, Majumdar S, Cristea MC, Han ES, Lee SJ, Wang EW, Fereday S, Traficante N, Salgia R, Werner T, et al. Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer. Nature Communications. 12: 3039. PMID 34031395 DOI: 10.1038/s41467-021-23171-3 |
0.297 |
|
| 2024 |
Chi F, Griffiths JI, Nath A, Bild AH. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells. Breast Cancer Research : Bcr. 26: 54. PMID 38553760 DOI: 10.1186/s13058-024-01808-7 |
0.28 |
|
| 2019 |
Nath A, Chang J, Huang RS. iMIRAGE: An R package to impute microRNA expression using protein-coding genes. Bioinformatics (Oxford, England). PMID 31860075 DOI: 10.1093/Bioinformatics/Btz939 |
0.273 |
|
| 2020 |
Chi F, Liu J, Brady SW, Cosgrove PA, Nath A, McQuerry JA, Majumdar S, Moos PJ, Chang JT, Kahn M, Bild AH. A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer. Translational Oncology. 14: 100946. PMID 33221681 DOI: 10.1016/j.tranon.2020.100946 |
0.271 |
|
| 2021 |
Lee AM, Ferdjallah A, Moore E, Kim DC, Nath A, Greengard E, Huang RS. Long Non-Coding RNA as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma. International Journal of Molecular Sciences. 22. PMID 34681828 DOI: 10.3390/ijms222011168 |
0.258 |
|
| 2023 |
Emond R, Griffiths JI, Grolmusz VK, Nath A, Chen J, Medina EF, Sousa RS, Synold T, Adler FR, Bild AH. Cell facilitation promotes growth and survival under drug pressure in breast cancer. Nature Communications. 14: 3851. PMID 37386030 DOI: 10.1038/s41467-023-39242-6 |
0.256 |
|
| 2022 |
Nath A, Cosgrove PA, Chang JT, Bild AH. Predicting clinical response to everolimus in ER+ breast cancers using machine-learning. Frontiers in Molecular Biosciences. 9: 981962. PMID 36304922 DOI: 10.3389/fmolb.2022.981962 |
0.249 |
|
| 2012 |
Nath A, Chan C. Relevance of Network Hierarchy in Cancer Drug-Target Selection Systems Biology in Cancer Research and Drug Discovery. 2147483647: 339-362. DOI: 10.1007/978-94-007-4819-4_15 |
0.247 |
|
| 2022 |
Nath A, Cohen AL, Bild AH. ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers. Molecular Systems Biology. 18: e10558. PMID 35671075 DOI: 10.15252/msb.202110558 |
0.244 |
|
| 2022 |
Bishara I, Chen J, Griffiths JI, Bild AH, Nath A. A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types. Frontiers in Genetics. 13: 982019. PMID 36506328 DOI: 10.3389/fgene.2022.982019 |
0.242 |
|
| 2020 |
Ferdjallah A, Lee AM, Moore E, Nath A, Huang RS. The role of long non-coding RNA ANRIL in chemosensitivity in osteosarcoma and clinical outcomes. Journal of Clinical Oncology. 38: e22515-e22515. DOI: 10.1200/jco.2020.38.15_suppl.e22515 |
0.241 |
|
| 2021 |
Nath A, Bild AH. Leveraging Single-Cell Approaches in Cancer Precision Medicine. Trends in Cancer. PMID 33563578 DOI: 10.1016/j.trecan.2021.01.007 |
0.24 |
|
| 2016 |
Dalgic E, Li I, Nath A, Chan C. GR-RNF43 Regulation In Colorectal Cancer Journal of Proteomics and Genomics Research. 1: 60-66. DOI: 10.14302/ISSN.2326-0793.JPGR-16-941 |
0.234 |
|
| 2023 |
Farmaki E, Nath A, Emond R, Karimi KL, Grolmusz VK, Cosgrove PA, Bild AH. ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer. Elife. 12. PMID 37772709 DOI: 10.7554/eLife.85898 |
0.221 |
|
| 2022 |
Nath A. Unraveling phenotypic plasticity and evolution in small cell lung cancer. Cell Systems. 13: 687-689. PMID 36137510 DOI: 10.1016/j.cels.2022.08.005 |
0.17 |
|
| 2022 |
Liu S, Song Y, Zhang IY, Zhang L, Gao H, Su Y, Yang Y, Yin S, Zheng Y, Ren L, Yin HH, Pillai R, Nath A, Medina EF, Cosgrove PA, et al. RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 35226341 DOI: 10.1007/s13311-022-01207-w |
0.103 |
|
| Hide low-probability matches. |